scispace - formally typeset
N

Noel Weidner

Researcher at University of California, San Diego

Publications -  77
Citations -  8444

Noel Weidner is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Sarcoma & Adenocarcinoma. The author has an hindex of 27, co-authored 77 publications receiving 8129 citations. Previous affiliations of Noel Weidner include Brigham and Women's Hospital.

Papers
More filters
Journal ArticleDOI

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

TL;DR: The number of microvessels per 200x field in the areas of most intensive neovascularization in an invasive breast carcinoma may be an independent predictor of metastatic disease either in axillary lymph nodes or at distant sites (or both).
Journal ArticleDOI

Diagnostic Relevance of Clonal Cytogenetic Aberrations in Malignant Soft-Tissue Tumors

TL;DR: Cytogenetic analyses reveal clonal chromosome aberrations in virtually all malignant soft-tissue tumors, particularly in small round-cell tumors in children.
Journal ArticleDOI

Pseudoangiomatous hyperplasia of mammary stroma. Some observations regarding its clinicopathologic spectrum.

TL;DR: The review of 200 consecutive breast specimens showed PHMS changes occurred in younger patients than the control population and were associated with fibrocystic changes, in fibroadenomas, in gynecomastia, in normal breast tissue, and in sclerosing lobular hyperplasia.
Journal ArticleDOI

Heterogeneity of Mast Cells at Multiple Body Sites: Fluorescent Determination of Avidin Binding and Immunofluorescent Determination of Chymase, Tryptase, and Carboxypeptidase Content

TL;DR: In this article, human mast cells from multiple sites were studied to determine heterogeneity of expression of chymase, tryptase, and/or carboxypeptidase and binding to avidin.
Journal ArticleDOI

TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location.

TL;DR: Prevalent TTF-1 positivity in TLs and peripheral carcinoids suggest that they may be histogenetically distinct from the central carcinoids, which are typically composed of TTF -1-negative, more rounded cells.